trending Market Intelligence /marketintelligence/en/news-insights/trending/3ltv3rk6kcpwaizc9jpdkw2 content esgSubNav
In This List

Editas Medicine names board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Editas Medicine names board member

Mass.-based biotech company Editas Medicine Inc. appointed Jessica Hopfield as a board member.

Hopfield is the chairperson of the board for Joslin Diabetes Center and serves as the lead independent director on the board at Insulet Corp.